# The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers

> **NCT05297097** · PHASE2 · UNKNOWN · sponsor: **TruDiagnostic** · enrollment: 30 (estimated)

## Conditions studied

- Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Trulacta breastmilk supplement

## Key facts

- **NCT ID:** NCT05297097
- **Lead sponsor:** TruDiagnostic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05297097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05297097, "The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05297097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*